|
ZNF611 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.94420002109075E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21720436349915E-11 |
| Normal-vs-Stage2 |
5.579000E-03 |
| Normal-vs-Stage3 |
5.038300E-03 |
| Normal-vs-Stage4 |
5.102400E-01 |
| Stage1-vs-Stage2 |
6.709200E-01 |
| Stage1-vs-Stage3 |
3.984100E-03 |
| Stage1-vs-Stage4 |
3.99349999735676E-08 |
| Stage2-vs-Stage3 |
2.172600E-01 |
| Stage2-vs-Stage4 |
1.536440E-02 |
| Stage3-vs-Stage4 |
3.834300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.82959999875487E-09 |
| Normal-vs-AfricanAmerican |
3.733400E-01 |
| Normal-vs-Asian |
7.224100E-02 |
| Caucasian-vs-AfricanAmerican |
5.702000E-03 |
| Caucasian-vs-Asian |
6.979200E-01 |
| AfricanAmerican-vs-Asian |
1.196550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27610050199212E-10 |
| Normal-vs-Female |
3.362800E-03 |
| Male-vs-Female |
4.761500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.857700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.96770002911262E-09 |
| Normal-vs-Age(61-80Yrs) |
6.1752000000026E-05 |
| Normal-vs-Age(81-100Yrs) |
2.845000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.443200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.091200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.344000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.885700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.773210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.620200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.682370E-02 |
| Normal-vs-Grade 2 |
7.02639946226213E-10 |
| Normal-vs-Grade 3 |
1.31520000001828E-06 |
| Normal-vs-Grade 4 |
6.582600E-01 |
| Grade 1-vs-Grade 2 |
1.521800E-01 |
| Grade 1-vs-Grade 3 |
1.295770E-01 |
| Grade 1-vs-Grade 4 |
1.353860E-02 |
| Grade 2-vs-Grade 3 |
1.067600E-01 |
| Grade 2-vs-Grade 4 |
1.43310000533248E-08 |
| Grade 3-vs-Grade 4 |
1.69641999999692E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.8519855627992E-13 |
| Normal-vs-ccB subtype |
2.221200E-04 |
| ccA subtype-vs-ccB subtype |
2.343300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12029999999042E-06 |
| Normal-vs-N1 |
5.801000E-01 |
| N0-vs-N1 |
3.256200E-01 |
|
|
